Pictet Asset Management’s Edwards Lifesciences EW Stock Holding History

Pictet Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.5M	Sell	343,016 -9,200	-3%	-$758K	0.03%	433
2025 Q4	$30M	Sell	352,216 -5,900	-2%	-$484K	0.03%	426
2025 Q3	$27.8M	Sell	358,116 -143,444	-29%	-$11.2M	0.03%	452
2025 Q2	$39.2M	Buy	501,560 +39,044	+8%	+$2.91M	0.04%	357
2025 Q1	$33.5M	Buy	462,516 +86,771	+23%	+$6.21M	0.04%	380
2024 Q4	$27.8M	Buy	375,745 +26,573	+8%	+$1.86M	0.03%	415
2024 Q3	$23M	Buy	349,172 +8,311	+2%	+$604K	0.03%	455
2024 Q2	$31.5M	Buy	340,861 +5,135	+2%	+$455K	0.04%	364
2024 Q1	$32.1M	Sell	335,726 -13,668	-4%	-$1.15M	0.03%	384
2023 Q4	$26.6M	Sell	349,394 -628,357	-64%	-$43.7M	0.03%	410
2023 Q3	$67.7M	Buy	+977,751	New	+$78.6M	0.08%	237

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pictet Asset Management's EW Position: Q1 2026 in Review

Pictet Asset Management reduced its Edwards Lifesciences (EW) stake by 2.6% in Q1 2026, selling an estimated $758K and leaving 343,016 shares worth $27.5M. The position accounts for 0.03% of the portfolio, ranked #433.

Pictet Asset Management first reported a position in EW in Q3 2023 and has held it in 11 quarters since. The position peaked at $67.7M in Q3 2023. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Pictet Asset Management held 343,016 shares of Edwards Lifesciences worth $27.5M as of Q1 2026.
Pictet Asset Management sold 9,200 Edwards Lifesciences shares in Q1 2026, an estimated $758K.
Edwards Lifesciences made up 0.03% of Pictet Asset Management's portfolio in Q1 2026, its #433 holding.
Pictet Asset Management first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 11 quarters since.
Pictet Asset Management's Edwards Lifesciences position peaked at $67.7M in Q3 2023.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.